skip to main content
Idioma:
Resultados 1 2 next page
Refinado por: Nome da Publicação: Annals Of Oncology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Cemiplimab, a human monoclonal anti-PD-1, plus radiotherapy (RT) in advanced non-small cell lung cancer (NSCLC): Results from a phase I expansion cohort (EC 2)
Cemiplimab, a human monoclonal anti-PD-1, plus radiotherapy (RT) in advanced non-small cell lung cancer (NSCLC): Results from a phase I expansion cohort (EC 2)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cemiplimab, a human monoclonal anti-PD-1, plus radiotherapy (RT) in advanced non-small cell lung cancer (NSCLC): Results from a phase I expansion cohort (EC 2)

Moreno, V. ; Gil-Martin, M. ; Johnson, M. ; Aljumaily, R. ; Lopez Criado, P. ; Northfelt, D.W. ; Crittenden, M. ; Jabbour, S. ; Rosen, L. ; Garrido Lopez, P. ; Hervás Morón, A. ; Rietschel, P. ; Mohan, K.K. ; Li, J. ; Stankevich, E. ; Rowlands, T. ; Feng, M. ; Lowy, I. ; Fury, M.G.

Annals of oncology, 2018-10, Vol.29, p.viii414-viii414 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
2
Impaired survival in resected glioblastoma multiforme patients treated with early chemoradiation
Impaired survival in resected glioblastoma multiforme patients treated with early chemoradiation
Material Type:
Artigo 		Adicionar ao Meu Espaço

Impaired survival in resected glioblastoma multiforme patients treated with early chemoradiation

del Carpio, L.P. ; Gomila, P. ; Camacho, S.D. ; Moron, S. ; Riudavets, M. ; Molto, C. ; Bujosa, A. ; Borrell, M. ; Teres, R. ; Martin, B. ; Gallardo, P. ; Acosta, E. ; Tilea, L. ; Soto, A. ; De Quintana, C. ; Craven-Bartle, J. ; Gallardo, A. ; Gomez, B. ; Bonilla, S. ; Gallego, O.

Annals of oncology, 2018-10, Vol.29, p.viii127-viii127 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
3
Association of efficacy and immune-related adverse events (irAEs) in patients with NSCLC receiving immune-checkpoint inhibitors (ICIs)
Association of efficacy and immune-related adverse events (irAEs) in patients with NSCLC receiving immune-checkpoint inhibitors (ICIs)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Association of efficacy and immune-related adverse events (irAEs) in patients with NSCLC receiving immune-checkpoint inhibitors (ICIs)

Riudavets Melia, M. ; Gabriela Sullivan, I. ; Barba Joaquín, A. ; Anguera Palacios, G. ; del Carpio, L.P. ; Molto Valiente, C. ; Camacho Arellano, S.D. ; Moron Asensio, S. ; Gomila Pons, P. ; Andres Granyó, M. ; Castillo Villegas, D. ; Facundo Molas, C. ; Garcia Planella, E. ; González Blanco, C. ; Barnadas Molins, A. ; Gich Saladich, I. ; Majem Tarruella, M.

Annals of oncology, 2018-10, Vol.29, p.viii509-viii509 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
4
388PImpaired survival in resected glioblastoma multiforme patients treated with early chemoradiation
388PImpaired survival in resected glioblastoma multiforme patients treated with early chemoradiation
Material Type:
Artigo 		Adicionar ao Meu Espaço

388PImpaired survival in resected glioblastoma multiforme patients treated with early chemoradiation

del Carpio, L P ; Gomila, P ; Camacho, S D ; Moron, S ; Riudavets, M ; Molto, C ; Bujosa, A ; Borrell, M ; Teres, R ; Martin, B ; Gallardo, P ; Acosta, E ; Tilea, L ; Soto, A ; De Quintana, C ; Craven-Bartle, J ; Gallardo, A ; Gomez, B ; Bonilla, S ; Gallego, O

Annals of oncology, 2018-10, Vol.29 (suppl_8) [Periódico revisado por pares]

Oxford University Press

Texto completo disponível

Citações Citado por
5
1409PAssociation of efficacy and immune-related adverse events (irAEs) in patients with NSCLC receiving immune-checkpoint inhibitors (ICIs)
1409PAssociation of efficacy and immune-related adverse events (irAEs) in patients with NSCLC receiving immune-checkpoint inhibitors (ICIs)
Material Type:
Artigo 		Adicionar ao Meu Espaço

1409PAssociation of efficacy and immune-related adverse events (irAEs) in patients with NSCLC receiving immune-checkpoint inhibitors (ICIs)

Riudavets Melia, M ; Gabriela Sullivan, I ; Barba Joaquín, A ; Anguera Palacios, G ; del Carpio, L P ; Molto Valiente, C ; Camacho Arellano, S D ; Moron Asensio, S ; Gomila Pons, P ; Andres Granyó, M ; Castillo Villegas, D ; Facundo Molas, C ; Garcia Planella, E ; González Blanco, C ; Barnadas Molins, A ; Gich Saladich, I ; Majem Tarruella, M

Annals of oncology, 2018-10, Vol.29 (suppl_8) [Periódico revisado por pares]

Oxford University Press

Texto completo disponível

Citações Citado por
6
1162PCemiplimab, a human monoclonal anti-PD-1, plus radiotherapy (RT) in advanced non-small cell lung cancer (NSCLC): Results from a phase I expansion cohort (EC 2)
1162PCemiplimab, a human monoclonal anti-PD-1, plus radiotherapy (RT) in advanced non-small cell lung cancer (NSCLC): Results from a phase I expansion cohort (EC 2)
Material Type:
Artigo 		Adicionar ao Meu Espaço

1162PCemiplimab, a human monoclonal anti-PD-1, plus radiotherapy (RT) in advanced non-small cell lung cancer (NSCLC): Results from a phase I expansion cohort (EC 2)

Moreno, V ; Gil-Martin, M ; Johnson, M ; Aljumaily, R ; Lopez Criado, P ; Northfelt, D W ; Crittenden, M ; Jabbour, S ; Rosen, L ; Garrido Lopez, P ; Hervás Morón, A ; Rietschel, P ; Mohan, K K ; Li, J ; Stankevich, E ; Rowlands, T ; Feng, M ; Lowy, I ; Fury, M G

Annals of oncology, 2018-10, Vol.29 (suppl_8) [Periódico revisado por pares]

Oxford University Press

Texto completo disponível

Citações Citado por
7
Cemiplimab, a human monoclonal anti-PD-1, plus radiotherapy (RT) in advanced non-small cell lung cancer (NSCLC): Results from a phase I expansion cohort (EC 2)
Cemiplimab, a human monoclonal anti-PD-1, plus radiotherapy (RT) in advanced non-small cell lung cancer (NSCLC): Results from a phase I expansion cohort (EC 2)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cemiplimab, a human monoclonal anti-PD-1, plus radiotherapy (RT) in advanced non-small cell lung cancer (NSCLC): Results from a phase I expansion cohort (EC 2)

Moreno, V. ; Gil-Martin, M. ; Johnson, M.L. ; Aljumaily, R. ; Lopez Criado, P. ; Northfelt, D.W. ; Crittenden, M. ; Jabbour, S. ; Rosen, L. ; Garrido, P. ; Hervás Morón, A. ; Rietschel, P. ; Mohan, K.K. ; Li, J. ; Stankevich, E. ; Feng, M. ; Lowy, I. ; Fury, M.G.

Annals of oncology, 2018-12, Vol.29, p.x26-x26 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
8
72PCemiplimab, a human monoclonal anti-PD-1, plus radiotherapy (RT) in advanced non-small cell lung cancer (NSCLC): Results from a phase I expansion cohort (EC 2)
72PCemiplimab, a human monoclonal anti-PD-1, plus radiotherapy (RT) in advanced non-small cell lung cancer (NSCLC): Results from a phase I expansion cohort (EC 2)
Material Type:
Artigo 		Adicionar ao Meu Espaço

72PCemiplimab, a human monoclonal anti-PD-1, plus radiotherapy (RT) in advanced non-small cell lung cancer (NSCLC): Results from a phase I expansion cohort (EC 2)

Moreno, V ; Gil-Martin, M ; Johnson, M L ; Aljumaily, R ; Lopez Criado, P ; Northfelt, D W ; Crittenden, M ; Jabbour, S ; Rosen, L ; Garrido, P ; Hervás Morón, A ; Rietschel, P ; Mohan, K K ; Li, J ; Stankevich, E ; Feng, M ; Lowy, I ; Fury, M G

Annals of oncology, 2018-12, Vol.29 (suppl_10) [Periódico revisado por pares]

Oxford University Press

Texto completo disponível

Citações Citado por
9
17P Dynamic changes of CT-radiomic and systemic immune-inflammatory features predict the response to immune checkpoint inhibitors in advanced NSCLC patients
17P Dynamic changes of CT-radiomic and systemic immune-inflammatory features predict the response to immune checkpoint inhibitors in advanced NSCLC patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

17P Dynamic changes of CT-radiomic and systemic immune-inflammatory features predict the response to immune checkpoint inhibitors in advanced NSCLC patients

Mazzaschi, G. ; Milanese, G. ; Moron Dalla Tor, L. ; Leo, L. ; Balbi, M. ; Trentini, F. ; Manini, M. ; Pavone, C. ; Silva, M. ; Ledda, R.E. ; Minari, R. ; Bordi, P. ; Buti, S. ; Leonetti, A. ; Roti, G. ; Quaini, F. ; Sverzellati, N. ; Tiseo, M.

Annals of oncology, 2021-12, Vol.32, p.S1380-S1381 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
10
P-11 Venous thromboembolism in colorectal cancer patients with BRAF mutation
P-11 Venous thromboembolism in colorectal cancer patients with BRAF mutation
Material Type:
Artigo 		Adicionar ao Meu Espaço

P-11 Venous thromboembolism in colorectal cancer patients with BRAF mutation

Ortega Morán, L. ; Pesántez, D. ; Brozos Vázquez, E. ; Fernández Garay, D. ; Lobo de Mena, M. ; Ribera Fernández, P. ; Sánchez Cánovas, M. ; Salgado Fernandez, M. ; García Pérez, E. ; Iriarte Moncho, E. ; Morón García, B. ; Font, C. ; Gallardo, E. ; Pérez Altozano, J. ; Muñoz Martín, A.

Annals of oncology, 2022-06, Vol.33, p.S249-S250 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
Resultados 1 2 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Refinar Meus Resultados

Data de Publicação 

De até
Refinar

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.